CarPartscom Inc
For the period ended Dec 30, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
PRTS$8.35+3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(In Thousands)
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · · · · Accumulated · · · · · · | ||||||||||||||||||||
| · · · · · · · Additional · · · · · Other · · · · · Total | ||||||||||||||||||||
| · · Common Stock · · Paid-in- · · Treasury · · Comprehensive · · Accumulated · · Stockholders’ | ||||||||||||||||||||
| · Shares · Amount · Capital · Stock · (Loss) Income · Deficit · Equity | ||||||||||||||||||||
| Balance, January 2, 2021 | 48,091 | | $51 | | $260,260 | | $(7,146) | | $(215) | $(169,461) | | $83,489 | ||||||||
| Net loss | — | | — | | — | | — | | — | | (10,339) | | (10,339) | |||||||
| Issuance of shares in connection with stock option exercise | 2,060 | | 2 | | 3,659 | | — | | — | | — | | 3,661 | |||||||
| Issuance of shares in connection with restricted stock units vesting | 2,665 | | 3 | | 986 | | — | | — | | — | | 989 | |||||||
| Issuance of stock awards | | 143 | | | — | | | 778 | | | — | | | — | | | — | | | 778 |
| Issuance of shares in connection with BOD fees | 1 | | — | | 23 | | — | | — | | — | | 23 | |||||||
| Registration costs - common stock | | — | | | — | | | (68) | | | — | | | — | | | — | | | (68) |
| Officers and directors stock purchase plan | | — | | | — | | | 4 | | | — | | | — | | | — | | | 4 |
| Share-based compensation | | — | | | — | | | 17,066 | | | — | | | — | | | — | | | 17,066 |
| Stock repurchase | | — | | | — | | | (45) | | | (479) | | | — | | | — | | | (524) |
| Actuarial gain on defined benefit plan | | — | | | — | | | — | | | — | | | 307 | | | — | | | 307 |
| Unrealized gain on deferred compensation trust assets | | — | | | — | | | — | | | — | | | 89 | | | — | | | 89 |
| Effect of changes in foreign currencies | — | | — | | — | | — | | 93 | | — | | 93 | |||||||
| Balance, January 1, 2022 | | 52,960 | | $56 | | $282,663 | | $(7,625) | | $274 | | $(179,800) | | $95,568 | ||||||
| Net loss | | — | | | — | | | — | | | — | | | — | | | (951) | | | (951) |
| Issuance of shares in connection with stock option exercise | | 738 | | | — | | | 1,284 | | | — | | | — | | | — | | | 1,284 |
| Issuance of shares in connection with restricted stock units vesting | | 872 | | | 1 | | | (1) | | | — | | | — | | | — | | | — |
| Issuance of stock awards to consultants | | 10 | | | — | | | 81 | | | — | | | — | | | — | | | 81 |
| Issuance of shares in connection with BOD fees | | 3 | | | — | | | 22 | | | — | | | — | | | — | | | 22 |
| Issuance of shares in connection with Employee Stock Purchase Plan ("ESPP") | | 107 | | | — | | | 795 | | | — | | | — | | | — | | | 795 |
| Officers and directors stock purchase plan | | 3 | | | — | | | 26 | | | — | | | — | | | — | | | 26 |
| Share-based compensation | | — | | | — | | | 12,395 | | | — | | | — | | | — | | | 12,395 |
| Actuarial gain on defined benefit plan | | — | | | — | | | — | | | — | | | 872 | | | — | | | 872 |
| Unrealized loss on deferred compensation trust assets | | — | | | — | | | — | | | — | | | (147) | | | — | | | (147) |
| Effect of changes in foreign currencies | | — | | | — | | | — | | | — | | | 127 | | | — | | | 127 |
| Balance, December 31, 2022 | | 54,693 | | $57 | | $297,265 | | $(7,625) | | $1,126 | | $(180,751) | | $110,072 | ||||||
| Net loss | | — | | | — | | | — | | | — | | | — | | | (8,223) | | | (8,223) |
| Issuance of shares in connection with stock option exercise | | 1,674 | | | 2 | | | 2,648 | | | — | | | — | | | — | | | 2,650 |
| Issuance of shares in connection with restricted stock units vesting | | 1,078 | | | 1 | | | — | | | — | | | — | | | — | | | 1 |
| Issuance of shares in connection with BOD fees | | 5 | | | — | | | 23 | | | — | | | — | | | — | | | 23 |
| Issuance of shares in connection with ESPP | | 114 | | | — | | | 483 | | | — | | | — | | | — | | | 483 |
| Share-based compensation | | — | | | — | | | 12,479 | | | — | | | — | | | — | | | 12,479 |
| Stock repurchase | | — | | | — | | | (24) | | | (4,287) | | | — | | | — | | | (4,311) |
| Actuarial loss on defined benefit plan | | — | | | — | | | — | | | — | | | (305) | | | — | | | (305) |
| Unrealized loss on deferred compensation trust assets | | — | | | — | | | — | | | — | | | (38) | | | — | | | (38) |
| Balance, December 30, 2023 | | 57,564 | | $60 | | $312,874 | | $(11,912) | | $783 | | $(188,974) | | $112,831 | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.